Afya (NASDAQ:AFYA) Posts Earnings Results, Misses Estimates By $0.01 EPS

Afya (NASDAQ:AFYA) issued its earnings results on Wednesday. The company reported $0.36 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.01), FiscalAI reports. Afya had a net margin of 20.55% and a return on equity of 17.58%. The firm had revenue of $190.16 million during the quarter, compared to analyst estimates of $190.28 million.

Afya Stock Down 3.7%

Shares of AFYA traded down $0.40 on Thursday, reaching $10.33. The company’s stock had a trading volume of 190,763 shares, compared to its average volume of 191,277. Afya has a twelve month low of $9.66 and a twelve month high of $16.16. The stock has a market capitalization of $968.16 million, a PE ratio of 6.30, a PEG ratio of 1.69 and a beta of 0.43. The company has a current ratio of 2.20, a quick ratio of 2.20 and a debt-to-equity ratio of 0.39. The firm has a fifty day moving average of $13.00 and a 200-day moving average of $14.05.

Insider Buying and Selling

In other Afya news, insider Santos Welder Ferreira sold 4,161 shares of the business’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $13.30, for a total transaction of $55,341.30. Following the completion of the sale, the insider directly owned 35,000 shares of the company’s stock, valued at approximately $465,500. The trade was a 10.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

AFYA has been the topic of a number of research reports. JPMorgan Chase & Co. dropped their price target on Afya from $19.00 to $17.50 and set an “overweight” rating on the stock in a research note on Tuesday, November 3rd. Bradesco Corretora raised Afya to an “outperform” rating and set a $17.00 price objective for the company in a research note on Thursday, September 24th. Citigroup upgraded Afya from a “neutral” rating to a “buy” rating and decreased their price objective for the company from $16.00 to $12.00 in a report on Tuesday, November 3rd. Zacks Research lowered Afya from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 3rd. Finally, Bank of America raised Afya from a “neutral” rating to a “buy” rating and set a $16.00 target price on the stock in a research report on Thursday, October 29th. Four analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Afya has a consensus rating of “Hold” and a consensus target price of $15.18.

About Afya

Afya Limited is a Brazilian medical education and digital health company. Its education business offers undergraduate medical degree programs, medical residency preparation, postgraduate courses and continuing education for health professionals. The company also provides digital tools and services for medical students and practicing physicians, including clinical reference, practice-management and learning resources. These offerings support professionals at different stages of their medical careers.